미국의 Neobiotechnologies와 공식대리점 계약을 체결했습니다.
https://www.neobiotechnologies.com/
NeoBiotechnologies Antibodies
Licensing as well as developing new Hybridoma Clones secreting monoclonal antibodies
to a wide variety of human proteins with an ultimate goal to cover the entire human proteome.
Antibody products are available for various applications through our OEM-partners.
Presently, company is holding more than 1,000 hybridomas.
